High PR3-ANCA positivity in a patient with chronic inflammatory demyelinating polyneuropathy

High PR3-ANCA positivity in a patient with chronic inflammatory demyelinating polyneuropathy

Proteinase 3 anti-neutrophil cytoplasmic antibody (PR3-ANCA) is reported to be highly specific to vasculitis compared to myeloperoxidase (MPO)-ANCA. We report a case of a 19-year-old woman with chronic inflammatory demyelinating polyneuropathy (CIDP) with high PR3-ANCA positivity. The patient respon...

Full description

Bibliographic Details
Main Authors:	Masanori Kurihara, Yu Kurata, Izumi Sugimoto, Yuki Hatanaka, Yasuhisa Sakurai
Format:	Article
Language:	English
Published:	Elsevier 2017-03-01
Series:	eNeurologicalSci
Subjects:	PR3-anti-neutrophil cytoplasmic antibody (PR3-ANCA) Chronic inflammatory demyelinating polyneuropathy (CIDP) Vasculitic neuropathy
Online Access:	http://www.sciencedirect.com/science/article/pii/S2405650216300314

Similar Items

Atypical pure sensory forms of chronic inflammatory demyelinating polyneuropathies
by: Eugen Gavriliuc, et al.
Published: (2019-06-01)

Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) in a Patient with Diabetes: a primary care perspective
by: Jordan Dever, et al.
Published: (2020-10-01)

Treatment of pediatric chronic inflammatory demyelinating polyneuropathy: Challenges, controversies, and questions
by: Jay Desai, et al.
Published: (2015-01-01)

Recurrent acute-onset of chronic inflammatory demyelinating polyneuropathy after COVID-19 vaccination
by: Tyler Grantham, et al.
Published: (2023-01-01)

The Misdiagnosis of CIDP: A Review
by: Jeffrey A. Allen
Published: (2020-03-01)

Anti-Neurofascin–Associated Nephrotic-Range Proteinuria in Chronic Inflammatory Demyelinating Polyneuropathy
by: Syed Bukhari, et al.
Published: (2020-11-01)

Temporal Dispersion and Duration of the Distal Compound Muscle Action Potential Do Not Distinguish Diabetic Sensorimotor Polyneuropathy From Chronic Inflammatory Demyelinating Polyneuropathy
by: Monica Alcantara, et al.
Published: (2022-04-01)

Clinical heterogeneity of chronic inflammatory demyelinating polyneuropathy: diagnostic challenges
by: A. S. Rizvanova, et al.
Published: (2020-03-01)

The Long-Term Course of Chronic Inflammatory Demyelinating Polyneuropathy: a Retrospective Study
by: Evgeniya A. Melnik, et al.
Published: (2023-12-01)

Tremor Associated with Chronic Inflammatory Demyelinating Polyneuropathy and Anti-Neurofascin-155 Antibodies
by: Laurent Bailly, et al.
Published: (2018-12-01)

Pathophysiology of the Different Clinical Phenotypes of Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
by: Edyta Dziadkowiak, et al.
Published: (2021-12-01)

Ultrasound neuroimaging in chronic inflammatory demyelinating polyneuropathy
by: N. B. Vuytsik, et al.
Published: (2017-02-01)

Clinical characteristics and primary outcomes of patients with ANCA-associated vasculitis and central diabetes insipidus
by: Xin Chen, et al.
Published: (2023-05-01)

Nerve Ultrasound Comparison Between Transthyretin Familial Amyloid Polyneuropathy and Chronic Inflammatory Demyelinating Polyneuropathy
by: Kang Du, et al.
Published: (2021-02-01)

A Transient Increase in the Serum ANCAs in Patients with SARS-CoV-2 Infection: A Signal of Subclinical Vasculitis or an Epiphenomenon with No Clinical Manifestations? A Pilot Study
by: Monica Gelzo, et al.
Published: (2021-08-01)

Systematic Histological Scoring Reveals More Prominent Interstitial Inflammation in Myeloperoxidase-ANCA Compared to Proteinase 3-ANCA Glomerulonephritis
by: Samy Hakroush, et al.
Published: (2021-03-01)

Vasculite ANCA associata in un paziente con trombofilia ereditaria
by: Giovanni Salvati, et al.
Published: (2014-09-01)

Clinical Utility of Serial Measurements of Antineutrophil Cytoplasmic Antibodies Targeting Proteinase 3 in ANCA-Associated Vasculitis
by: Gwen E. Thompson, et al.
Published: (2020-09-01)

Pulmonary granulomas in a patient with positive ANCA and history of tuberculosis: case report
by: B. Wong, et al.
Published: (2020-08-01)

Fatigue in patients with chronic inflammatory demyelinating polyneuropathy
by: R. A. Gapeshin, et al.
Published: (2021-02-01)

Childhood subacute inflammatory demyelinating polyneuropathy
by: Chia-Yu Hsu, et al.
Published: (2011-11-01)

Chronic inflammatory demyelinating polyneuropathy with hypoglossal nerve involvement and inverted Beevor’s sign: case report
by: Huajian Zhao, et al.
Published: (2021-06-01)

Improvement of indirect immunofluorescence technique to detect antineutrophil cytoplasmic antibodies and its impact on test positivity rate
by: E.B. Zarur, et al.
Published: (2023-07-01)

Pain in Chronic Inflammatory Demyelinating Polyradiculoneuropathy: A Systematic Review and Meta-Analysis
by: Athena Michaelides, et al.
Published: (2019-06-01)

Clinical and neurophysiological correlation in axonal and demyelinating polyneuropathy
by: Kamel Mahmoud Ali Hewedi, et al.
Published: (2020-06-01)

C-Reactive Protein Levels Are Associated with Complement C4 Deposits and Interstitial Arteritis in ANCA-Associated Renal Vasculitis
by: Peter Korsten, et al.
Published: (2023-02-01)

Galactosylation and Sialylation Levels of IgG Predict Relapse in Patients With PR3-ANCA Associated Vasculitis
by: Michael J. Kemna, et al.
Published: (2017-03-01)

Dose Adjustment of Subcutaneous IgG in Chronic Inflammatory Demyelinating Polyneuropathy
by: Alanood Alsolaihim, et al.
Published: (2020-02-01)

Depression with chronic inflammatory demyelinating polyneuropathy
by: Arun Marwale, et al.
Published: (2018-01-01)

Single-center experience of induction therapy in non-systemic vasculitic neuropathy
by: Christian Schneider, et al.
Published: (2022-08-01)

Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and fibromyalgia: PR3-versus MPO-ANCA-associated vasculitis, an exploratory cross-sectional studyResearch in context
by: Charmaine van Eeden, et al.
Published: (2023-04-01)

Clinical, electrophysiological, and histopathological profile of biopsy-proven vasculitic neuropathy
by: Suchitra Deolalikar, et al.
Published: (2020-01-01)

The characteristics of chronic inflammatory demyelinating polyneuropathy in patients with diabetes mellitus
by: R. A. Gapeshin, et al.
Published: (2020-06-01)

PR3 vasculitis presenting with symptomatic splenic and renal infarction: a case report and literature review
by: M. J. Bottomley, et al.
Published: (2019-03-01)

A Severe Course of Relapsing-Remitting Acute-Onset Chronic Inflammatory Demyelinating Polyneuropathy in a Young Man
by: Anna P. Patnaik, et al.
Published: (2021-02-01)

Microscopic polyangiitis associated with thymic tumor: a case report and review of the literature
by: Yasunori Miyamoto, et al.
Published: (2019-04-01)

Glomerulonefritis rápidamente progresiva asociada a endocarditis afebril y anca anti-proteinasa 3
by: Esmeralda Castillo Rodríguez, et al.
Published: (2017-03-01)

Calprotectin in Chronic Inflammatory Demyelinating Polyneuropathy and Variants—A Potential Novel Biomarker of Disease Activity
by: Frauke Stascheit, et al.
Published: (2021-09-01)

Serum neurofilament light chain in chronic inflammatory demyelinating polyneuropathy
by: Tomohiro Hayashi, et al.
Published: (2021-05-01)

An unsuspected histopathological finding —concomitant IgA nephropathy in a patient with ANCA-associated vasculitis: a case report and literature review
by: Maciej Tota, et al.
Published: (2023-08-01)